Subject: British Team to Test Possible AIDS Vaccine
Date: Published: 4/26/88 28 lines
Source:  WALL STREET JOURNAL. Copyright Dow Jones & Co. Inc. 

   British Team to Test
   Possible AIDS Vaccine
   Of Viral Technologies

   WASHINGTON -- Viral Technologies Inc. said a British
research team received regulatory approval to start clinical
trials of the company's potential AIDS vaccine.
   The company said it expects that the initial trial, meant
primarily to test whether the product is safe, should begin
this summer at St. Stephen's Hospital, London, and ultimately
involve 24 volunteers.
   At present, the company said, the research team has
approval to do trials in people who have been infected with
the AIDS virus but haven't yet shown any symptoms of AIDS. 
The researchers will seek approval also to test people who
haven't been infected.
Viral Technologies is a joint venture of CEL-SCI Corp.,
Alexandria, Va., and Alpha 1 Biomedicals Inc., Washington.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]